Back to search

Article

Effective Treatment of a BRAF V600E-Mutant Epithelioid Glioblastoma Patient By Vemurafenib: A Case Report

2020-11-23

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> Novel therapeutic targets in epithelioid glioblastoma (E-GBM) patients are urgently needed. About half of these tumors show the point mutations of the B-Raf proto-oncogene (BRAF). Therefore, this is a target of special interest for this group of patients. Meanwhile, unlike conventional glioblastoma, E-GBM lacks specific prognostic markers.<bold>Case presentation...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
079ce75a-5408-5ae0-a28e-a49298ecc59d
DOI
10.21203/rs.3.rs-112130/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effective Treatment of a BRAF V600E-Mutant Epithelioid Glioblastoma Patient By Vemurafenib: A Case ReportDOI 10.21203/rs.3.rs-112130/v1
Select a neighboring publication to make it the new centre.